These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 12414626

  • 1. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C.
    Cancer Res; 2002 Nov 01; 62(21):6039-44. PubMed ID: 12414626
    [Abstract] [Full Text] [Related]

  • 2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 3. Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells.
    Gravina GL, Festuccia C, Angelucci A, Poletti A, Capuano D, Vicentini C, Motta M, Bologna M.
    Int J Oncol; 2004 Jul 01; 25(1):97-104. PubMed ID: 15201994
    [Abstract] [Full Text] [Related]

  • 4. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2.
    Murillo H, Schmidt LJ, Tindall DJ.
    Cancer Res; 2001 Oct 15; 61(20):7408-12. PubMed ID: 11606371
    [Abstract] [Full Text] [Related]

  • 5. Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.
    Iacopino F, Lama G, Angelucci C, Sica G.
    Int J Oncol; 2006 Jul 15; 29(1):237-47. PubMed ID: 16773205
    [Abstract] [Full Text] [Related]

  • 6. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S, Levy G, Hanoch T, Naor Z, Seger R.
    Cancer Res; 2004 Aug 15; 64(16):5736-44. PubMed ID: 15313914
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 15; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M, Asim M, Eskelinen H, Linke T, Baniahmad A.
    J Mol Endocrinol; 2009 May 15; 42(5):429-35. PubMed ID: 19223455
    [Abstract] [Full Text] [Related]

  • 9. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C.
    Cancer Res; 2003 Nov 01; 63(21):7106-12. PubMed ID: 14612503
    [Abstract] [Full Text] [Related]

  • 10. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH, Neithardt A, Chu DB, Shah FB, Catt KJ.
    J Cell Physiol; 2006 Jan 01; 206(1):47-57. PubMed ID: 15920762
    [Abstract] [Full Text] [Related]

  • 11. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG, Musti AM, Lanzino M, Panno ML, Turano E, Zumpano R, Belfiore A, Andò S, Maggiolini M.
    Int J Biochem Cell Biol; 2009 Mar 01; 41(3):603-14. PubMed ID: 18692155
    [Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 13. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M, Latham DE, Delaney MA, Chakravarti A.
    Oncogene; 2005 Apr 07; 24(15):2474-82. PubMed ID: 15735703
    [Abstract] [Full Text] [Related]

  • 14. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
    Hecquet C, Lefevre G, Valtink M, Engelmann K, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2002 Sep 07; 43(9):3091-8. PubMed ID: 12202534
    [Abstract] [Full Text] [Related]

  • 15. Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.
    Minamiguchi K, Kawada M, Ohba S, Takamoto K, Ishizuka M.
    Mol Cell Endocrinol; 2004 Feb 12; 214(1-2):175-87. PubMed ID: 15062556
    [Abstract] [Full Text] [Related]

  • 16. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells.
    Ye D, Mendelsohn J, Fan Z.
    Clin Cancer Res; 1999 Aug 12; 5(8):2171-7. PubMed ID: 10473102
    [Abstract] [Full Text] [Related]

  • 17. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
    Xu Y, Chen SY, Ross KN, Balk SP.
    Cancer Res; 2006 Aug 01; 66(15):7783-92. PubMed ID: 16885382
    [Abstract] [Full Text] [Related]

  • 18. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T, Nakamura K, Araki H, Kusaka M, Yamaoka M.
    Cancer Res; 2003 Sep 01; 63(17):5622-8. PubMed ID: 14500404
    [Abstract] [Full Text] [Related]

  • 19. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S, Lunn JA, Santiskulvong C, Rozengurt E.
    Cancer Res; 2003 May 15; 63(10):2379-87. PubMed ID: 12750255
    [Abstract] [Full Text] [Related]

  • 20. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M, Miyamoto M.
    Cancer Res; 2003 Jan 01; 63(1):149-53. PubMed ID: 12517791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.